Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8029.80 | 1445 / 1445 | 100% | 78.35 | 183 / 183 |
intestine | 100% | 9147.46 | 966 / 966 | 100% | 99.30 | 527 / 527 |
kidney | 100% | 9841.88 | 89 / 89 | 100% | 193.37 | 901 / 901 |
liver | 100% | 7353.02 | 226 / 226 | 100% | 98.13 | 406 / 406 |
ovary | 100% | 5347.12 | 180 / 180 | 100% | 69.49 | 430 / 430 |
uterus | 100% | 5950.24 | 170 / 170 | 100% | 91.64 | 459 / 459 |
thymus | 100% | 6710.99 | 652 / 653 | 100% | 89.60 | 605 / 605 |
pancreas | 100% | 5305.32 | 327 / 328 | 100% | 122.14 | 178 / 178 |
lung | 100% | 12202.65 | 577 / 578 | 100% | 85.64 | 1153 / 1155 |
stomach | 100% | 6274.57 | 359 / 359 | 100% | 85.33 | 285 / 286 |
prostate | 100% | 6745.42 | 245 / 245 | 100% | 64.28 | 500 / 502 |
bladder | 100% | 7447.48 | 21 / 21 | 99% | 83.67 | 501 / 504 |
breast | 100% | 12174.22 | 459 / 459 | 99% | 77.64 | 1110 / 1118 |
skin | 100% | 7605.46 | 1808 / 1809 | 99% | 69.03 | 468 / 472 |
adrenal gland | 100% | 6239.26 | 258 / 258 | 97% | 49.69 | 223 / 230 |
brain | 94% | 2922.57 | 2488 / 2642 | 100% | 53.73 | 705 / 705 |
adipose | 100% | 13607.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 64.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 189.83 | 29 / 29 |
muscle | 100% | 14813.67 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 24342.62 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 13348.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 131.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.39 | 1 / 1 |
blood vessel | 100% | 6990.03 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 6949.26 | 850 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0006952 | Biological process | defense response |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0006954 | Biological process | inflammatory response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006412 | Biological process | translation |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0009101 | Biological process | glycoprotein biosynthetic process |
GO_1903003 | Biological process | positive regulation of protein deubiquitination |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007159 | Biological process | leukocyte cell-cell adhesion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0042802 | Molecular function | identical protein binding |
GO_0051019 | Molecular function | mitogen-activated protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TNIP1 |
Protein name | TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1) (ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1) (Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein) (VAN) (hVAN) TNFAIP3 interacting protein 1 |
Synonyms | KIAA0113 NAF1 |
Description | FUNCTION: Inhibits NF-kappa-B activation and TNF-induced NF-kappa-B-dependent gene expression by regulating TAX1BP1 and A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG . Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection. . |
Accessions | ENST00000517504.5 E7EW15 ENST00000520931.5 [Q15025-3] ENST00000315050.11 [Q15025-1] ENST00000519339.5 ENST00000522226.5 [Q15025-1] ENST00000521001.1 E7EW68 A0A0A0MRZ4 ENST00000524280.5 [Q15025-5] ENST00000520695.5 Q15025 ENST00000523200.5 [Q15025-4] E7EWG2 E7EMV7 ENST00000389378.6 ENST00000522100.5 ENST00000523338.5 [Q15025-2] ENST00000610535.5 [Q15025-4] H0YC17 ENST00000521591.6 [Q15025-1] ENST00000610874.4 [Q15025-5] ENST00000518977.5 [Q15025-2] |